Combination approach showed promise for treating rare, aggressive cancers
On Nov. 12, 2024, a research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that…
Biotechnology | Disease | Life Science History | Life Science News | NIH | Oncology | Radiology | Therapeutics | Women's Health
American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
FDA approved first oral hormone therapy for teating advanced prostate cancer
On Dec. 18, 2020, tthe U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult…
FDA approved first PSMA-targeted PET imaging drug for men with prostate cancer
On Dec. 1, 2020, the FDA approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) ï¾– the first drug for…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
Biotechnology | Diagnostics | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics
Keck School of Medicine announced $26.5 million grant to fund firstï¾ large-scale study on African-American men with prostate cancer
On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…
FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…
Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
New prostate cancer therapy investigated at Vanderbilt University Medical Center
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
Korff estate gifted $5 million to advance prostate cancer research and treatments in Nebraska
On Nov. 18, 2015, the estate of Glenn Korff gifted $5 million to the Fred & Pamela Buffett…
Rutgers Cancer Institute of New Jersey was one of seven worldwide sites to offer debulking prostatectomy
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On March 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
PROVENGE was approved by the FDA
On Apr. 29, 2010, the FDA approved sipuleucel-T (PROVENGE), made by the Dendreon Corp., an autologous cellular immunotherapy…
The largest-ever prostate cancer prevention study showed that Selenium and Vitamin E do not help prevent prostate cancer
On Dec. 9, 2008, in contrast with earlier research suggesting that dietary supplementation with selenium and vitamin E…
National Cancer Institute researchers discovered common variations in gene segments that increase risk for prostate cancer
On Feb. 10, 2008, National Cancer Institute (NCI) researchers reported that a set of genetic variations in at…
National Cancer Institute researchers discovered common variation in a gene segment that increases risk for prostate cancer
On Apr. 1, 2007, National Cancer Institute (NCI) researchers reported that a variation in a portion of DNA…
The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
National Cancer Institute launched a cancer biorepository pilot project to standardize biospecimen collection
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
Results from the Prostate Cancer Prevention Trial showed men taking finasteride had 25 percent fewer diagnoses of prostate cancer than men taking placebo
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics
Results of the Prostate Cancer Prevention Trial were announced
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
The Winship Cancer Institute received a $10 million award from the U.S. Dept of Defense for prostate cancer research
On Mar. 24, 2003, the Winship Cancer Institute at Emory University announced it had received a $10 million…
NCI and FDA scientists reported patterns of proteins found in patients’ blood can distinguish between prostate cancer and benign conditions
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
The Hutchinson Cancer Research Center played key role in largest-ever prostate-cancer prevention study
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
Dendreon Corporation launched its Initial Public Offering
On Jun. 16, 2000, Dendreon announced its initial public offering of 4,500,000 shares of common stock at $10.00…
The Prostate Centre at VGH received $20 million donation by Vancouver businessman Jim Pattison
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
Mouse model of prostate cancer was developed at Washington University – St Louis
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
The Prostate Centre at VGH was founded
In 1998, the The Prostate Centre at VGH, now known as the Vancouver Prostate Centre, was founded. The…
The NIH Revitalization Act of 1993, PL 103-43, was signed
On Jun. 10, 1993, the NIH Revitalization Act of 1993, P.L. 103-43, was signed. The act encouraged the…
Dendreon Corporation was founded
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…